Combination of HIFU with sulfur hexafluoride microbubbles in the treatment of solitary uterine fibroids: a systematic review and meta-analysis
Authors:
- 11 November 2023
- journal article
- review article
- Published by Springer Nature in European Radiology
- Vol. 34 (6) , 3786-3794
Abstract
Objectives To assess the efficacy and safety of sulfur hexafluoride microbubbles on ultrasound-guided high-intensity focused ultrasound (HIFU) ablation of uterine fibroids. Methods Studies that compared HIFU-microbubble combination with HIFU-only in patients with uterine fibroids were searched from inception to April 2022. The standardized mean difference (SMD) or relative risk (RR) with 95% confidence interval (CI) for different outcome parameters was calculated. Results Seven studies were included, with a total of 901 patients (519 in the combination group and 382 in the HIFU-only group). The energy consumption for treating 1 cm3 of the lesion in the combination group was less than that in the HIFU-only group [SMD = − 2.19, 95%CI (− 3.81, − 0.57), p = 0.008]. The use of microbubbles was associated with shortening the duration of the treatment and sonication [SMD = − 2.60, 95%CI (− 4.09, − 1.10), p = 0.0007; SMD = − 2.11, 95%CI (− 3.30, − 0.92), p = 0.0005]. The rates of significant greyscale changes during HIFU were greater in the combination group, as well as the increase of non-perfused volume ratio [RR = 1.26, 95%CI (1.04, 1.54), p = 0.02; SMD = 0.32, 95%CI (0.03, 0.61), p = 0.03]. The average sonication durations to reach significant greyscale changes and for ablating 1 cm3 of the fibroid lesion were shorter in the combination group [SMD = − 1.24, 95%CI (− 2.02, − 0.45), p = 0.002; SMD = − 0.22, 95%CI (− 0.42, − 0.02), p = 0.03]. The two groups had similar post-HIFU adverse effects, while the combination group had fewer intraprocedural adverse events like abdominal pain, sacrum pain, and leg pain. Conclusions Sulfur hexafluoride microbubbles can be safely used to enhance and accelerate the ablation effects of HIFU in the treatment of uterine fibroids. Clinical relevance statement The combination of HIFU with sulfur hexafluoride microbubbles offers a promising non-invasive treatment option for patients with uterine fibroids. Key Points • Sulfur hexafluoride microbubbles combined with ultrasound-guided high-intensity focused ultrasound (USgHIFU) has potential advantages in the treatment of uterine fibroids. • Sulfur hexafluoride microbubbles not only enhance the effects of USgHIFU treatment for uterine fibroids but also shorten its duration. • Sulfur hexafluoride microbubbles do not increase the incidence of USgHIFU-related adverse events in the treatment of uterine fibroids.Keywords
This publication has 35 references indexed in Scilit:
- Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatmentDrug Design, Development and Therapy, 2013
- Therapeutic management of uterine fibroid tumors: updated French guidelinesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and TheranosticsJournal of Nuclear Medicine, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Indeterminate Focal Liver Lesions Incidentally Discovered at Gray-Scale USInvestigative Radiology, 2011
- Enhanced Ablation of High Intensity Focused Ultrasound with Microbubbles: An Experimental Study on Rabbit Hepatic VX2 TumorsCardioVascular and Interventional Radiology, 2010
- Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction?European Heart Journal, 2007
- The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigationsUltrasound in Medicine & Biology, 2006
- Uterine Fibroids: The Elephant in the RoomScience, 2005
- Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasoundUltrasound in Medicine & Biology, 2004